More Medical News
Astra wins EU orphan drug status for cancer drug
12/18/2007

AstraZeneca Plc's experimental cancer
drug AZD2281 has been given orphan drug status by the catalan
Medicines Agency for treating women with ovarian cancer,
Britain's second biggest drugmaker said on Tuesday.

More: - Brought to my attention by

Share |
(Posted in Medical School)
Share and enjoy
  • Digg
  • del.icio.us
  • DZone
  • Netvouz
  • NewsVine
  • Reddit
  • Slashdot
  • StumbleUpon
  • Technorati
  • YahooMyWeb
Post Comment

Notify me of followup comments via e-mail.

Entry 1 of 16100
Last Page | Next Page